[go: up one dir, main page]

NO20054982L - Flytende farmasoytiske formuleringer for FSH og LH sammen med et ikke-ionisk surfaktant - Google Patents

Flytende farmasoytiske formuleringer for FSH og LH sammen med et ikke-ionisk surfaktant

Info

Publication number
NO20054982L
NO20054982L NO20054982A NO20054982A NO20054982L NO 20054982 L NO20054982 L NO 20054982L NO 20054982 A NO20054982 A NO 20054982A NO 20054982 A NO20054982 A NO 20054982A NO 20054982 L NO20054982 L NO 20054982L
Authority
NO
Norway
Prior art keywords
fsh
nonionic surfactant
pharmaceutical formulations
liquid pharmaceutical
liquid
Prior art date
Application number
NO20054982A
Other languages
English (en)
Other versions
NO330214B1 (no
Inventor
Fabrizio Samaritani
Piergiorgio Donati
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33135521&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20054982(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Publication of NO20054982L publication Critical patent/NO20054982L/no
Publication of NO330214B1 publication Critical patent/NO330214B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
NO20054982A 2003-04-02 2005-10-26 Flytende farmasoytisk sammensetninger omfattende follikkelstimulerende hormon (FSH) og/eller luteiniserende hormon (LH) sammen med et overflateaktivt middel, fremstilte artikler omfattende samme, og fremgangsmater for fremstilling av samme. NO330214B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP03100882 2003-04-02
EP03101543 2003-05-27
EP03101828 2003-06-20
PCT/EP2004/050432 WO2004087213A1 (en) 2003-04-02 2004-04-02 Liquid pharmaceutical formulations of fsh and lh together with a non-ionic surfactant

Publications (2)

Publication Number Publication Date
NO20054982L true NO20054982L (no) 2005-10-26
NO330214B1 NO330214B1 (no) 2011-03-07

Family

ID=33135521

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054982A NO330214B1 (no) 2003-04-02 2005-10-26 Flytende farmasoytisk sammensetninger omfattende follikkelstimulerende hormon (FSH) og/eller luteiniserende hormon (LH) sammen med et overflateaktivt middel, fremstilte artikler omfattende samme, og fremgangsmater for fremstilling av samme.

Country Status (24)

Country Link
US (1) US7741268B2 (no)
EP (1) EP1610822B2 (no)
JP (1) JP4699991B2 (no)
KR (1) KR101105486B1 (no)
AR (1) AR043972A1 (no)
AT (1) ATE492292T2 (no)
AU (1) AU2004226666B9 (no)
BR (1) BRPI0409532B8 (no)
CA (1) CA2518903C (no)
CY (1) CY1111291T1 (no)
DE (1) DE602004030673D1 (no)
DK (1) DK1610822T4 (no)
EA (1) EA012565B1 (no)
HR (1) HRP20100727T4 (no)
IL (1) IL171151A (no)
ME (1) ME00217B (no)
MX (1) MXPA05010635A (no)
NO (1) NO330214B1 (no)
NZ (1) NZ542247A (no)
PL (1) PL1610822T5 (no)
PT (1) PT1610822E (no)
RS (2) RS20050737A (no)
SI (1) SI1610822T2 (no)
WO (1) WO2004087213A1 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY139088A (en) * 2005-02-21 2009-08-28 Lg Life Sciences Ltd Sustained release composition of protein drug
TWI369401B (en) * 2005-07-05 2012-08-01 Ares Trading Sa Serum-free culture medium for the production of recombinant gonadotropins
CA2612613A1 (en) 2005-09-14 2007-03-22 Mara Rossi Method for the determination of poloxamers
KR101105871B1 (ko) * 2005-09-27 2012-01-16 주식회사 엘지생명과학 인 난포자극호르몬의 안정한 용액 제형
RS52566B (sr) * 2007-11-01 2013-04-30 Merck Serono S.A. Tečne formulacije lh
KR101573773B1 (ko) * 2008-02-08 2015-12-02 바이오제너릭스 게엠베하 Ｆｓｈ의 액체 포뮬레이션
CN101269215B (zh) * 2008-05-15 2011-03-23 上海天伟生物制药有限公司 一种糖蛋白激素组合物
CN102309747B (zh) * 2008-09-17 2013-04-17 上海天伟生物制药有限公司 高纯度绝经期促性腺素冻干针剂
US8329649B2 (en) * 2008-11-04 2012-12-11 Aska Pharmaceutical Co., Ltd. Aqueous composition containing follicle-stimulating hormone and histidine
CA2755927A1 (en) 2009-04-01 2010-10-14 Biogenerix Ag Method for purifying recombinant fsh
EP2325194A1 (en) 2009-11-24 2011-05-25 Glycotope GmbH Process for the purification of glycoproteins
CN102100908B (zh) * 2009-12-22 2013-05-08 上海天伟生物制药有限公司 一种蛋白质组合物
WO2012127500A2 (en) * 2011-03-11 2012-09-27 Sanzyme Limited Composition for spermatogenesis
US20160024181A1 (en) 2013-03-13 2016-01-28 Moderna Therapeutics, Inc. Long-lived polynucleotide molecules
WO2015075743A1 (en) * 2013-11-12 2015-05-28 Cadila Healthcare Limited Formulation for gonadotropins
EP3145950B1 (en) * 2014-05-23 2019-01-09 Instituto Massone S.A. A process for obtaining hmg-up (human menopausal gonadotropin with ultra-purity grade) and a composition free of contaminants
US11376220B2 (en) 2017-06-30 2022-07-05 Therio, LLC Single-injection methods and formulations to induce and control multiple ovarian follicles in bovine, caprine, ovine, camelid and other female animals
TW202348250A (zh) * 2017-07-24 2023-12-16 美商再生元醫藥公司 穩定化之抗體組合物及其製法

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB839300A (en) 1957-09-05 1960-06-29 Organon Labor Ltd Adrenocorticotropic hormone preparations and process for making same
FR3819M (fr) * 1963-03-11 1966-01-10 Serono Ist Farm Nouvelle hormone hypophysaire a activité différenciée.
EP0082481B2 (en) 1981-12-23 1990-09-12 Schering Corporation Stabilised alpha-interferon formulations and their preparation
JPS5921613A (ja) 1982-07-28 1984-02-03 Takeda Chem Ind Ltd 直腸投与製剤
US4659696A (en) 1982-04-30 1987-04-21 Takeda Chemical Industries, Ltd. Pharmaceutical composition and its nasal or vaginal use
US4746508A (en) 1983-06-06 1988-05-24 Beth Israel Hospital Assn. Drug administration
US5639639A (en) 1983-11-02 1997-06-17 Genzyme Corporation Recombinant heterodimeric human fertility hormones, and methods, cells, vectors and DNA for the production thereof
US4839341A (en) 1984-05-29 1989-06-13 Eli Lilly And Company Stabilized insulin formulations
US4589402A (en) 1984-07-26 1986-05-20 Serono Laboratories, Inc. Method of in vitro fertilization
US4962091A (en) 1986-05-23 1990-10-09 Syntex (U.S.A.) Inc. Controlled release of macromolecular polypeptides
US4780451B1 (en) 1987-01-23 1995-04-04 Asua International Inc Composition and method for producing superovulation in cattle
US5162306A (en) 1987-01-23 1992-11-10 Donaldson Lloyd E Composition and method for producing superovulation in mammals
IT1206302B (it) 1987-06-26 1989-04-14 Serono Cesare Ist Ricerca Ormone follicolo-stimolante urinario
DE3863908D1 (de) 1987-11-27 1991-08-29 Akzo Nv Stabilisierung von antikoerpern.
US5096885A (en) * 1988-04-15 1992-03-17 Genentech, Inc. Human growth hormone formulation
US5087615A (en) 1989-03-17 1992-02-11 Applied Research Systems Ars Holding N.V. Novel method of ovulation induction in humans
US5733572A (en) 1989-12-22 1998-03-31 Imarx Pharmaceutical Corp. Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
IE64738B1 (en) 1990-03-20 1995-09-06 Akzo Nv Stabilized gonadotropin containing preparations
US5270057A (en) 1990-03-20 1993-12-14 Akzo N.V. Stabilized gonadotropin containing preparations
US5384132A (en) 1990-03-20 1995-01-24 Akzo N.V. Stabilized gonadotropin containing preparations
US5374620A (en) 1990-06-07 1994-12-20 Genentech, Inc. Growth-promoting composition and its use
DE4117078A1 (de) 1991-05-25 1992-11-26 Boehringer Ingelheim Kg Verfahren zur herstellung therapeutisch anwendbarer aerosole
US5508261A (en) 1991-06-18 1996-04-16 University Of Medicine & Dentistry Of New Jersey Analogs of glycoprotein hormones having altered receptor binding specificity and activity and methods for preparing and using same
DE69231129D1 (de) 1991-06-18 2000-07-06 Univ New Jersey Med Analoga von glykoproteinhormonen mit geänderter rezeptorbindungsspezifität und aktivität und verfahren zur darstellung und verwendung derselben
IT1250075B (it) 1991-12-18 1995-03-30 Serono Cesare Ist Ricerca Composizioni farmaceutiche contenenti gonadotropine.
US5356876A (en) * 1992-01-13 1994-10-18 Trinity University Methods of terminating pregnancy
GB9211268D0 (en) 1992-05-28 1992-07-15 Ici Plc Salts of basic peptides with carboxyterminated polyesters
ES2153385T5 (es) 1992-07-31 2008-09-01 Genentech, Inc. Composicion acuosa a base de hormona del crecimiento humana.
US5661125A (en) 1992-08-06 1997-08-26 Amgen, Inc. Stable and preserved erythropoietin compositions
EP0682524B1 (en) * 1993-02-02 2001-10-04 XOMA Technology Ltd. Pharmaceutical compositions containing bactericidal permeability increasing protein and a surfactant
US6238890B1 (en) 1994-02-18 2001-05-29 Washington University Single chain forms of the glycoprotein hormone quartet
ATE178789T1 (de) 1994-02-21 1999-04-15 Takeda Chemical Industries Ltd Polyester matrix für eine pharmazeutische zusammensetzung mit verzögerter freigabe
US5580856A (en) 1994-07-15 1996-12-03 Prestrelski; Steven J. Formulation of a reconstituted protein, and method and kit for the production thereof
US6524557B1 (en) * 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
ATE223221T1 (de) 1994-12-22 2002-09-15 Ortho Pharma Corp Lösliche arzneizusammensetzungen enthaltend 2- chloro-2'-deoxyadenosine
DK0814778T3 (da) * 1995-03-10 2001-09-17 Roche Diagnostics Gmbh Polypeptidholdige farmaceutiske administrationsformer i form af mikropartikler og fremgangsmåde til fremstilling deraf
JP2758154B2 (ja) 1995-04-06 1998-05-28 エフ・ホフマン−ラ ロシユ アーゲー インターフェロンを含む液体製剤
FR2733914B1 (fr) * 1995-05-11 1997-08-01 Sanofi Sa Composition de liquide stable contenant de l'urate oxydase et composition lyophilisee pour sa preparation
US6267958B1 (en) 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
MX9800684A (es) 1995-07-27 1998-04-30 Genentech Inc Formulacion de proteinas liofilizadas isotonicas estables.
PT862452E (pt) 1995-11-07 2004-04-30 Genentech Inc Formulacao de estabilizacao para o ngf
CN1244110A (zh) 1996-12-23 2000-02-09 诺沃挪第克公司 用于储存液体药物的环状烃聚合物药物容器
US6136784A (en) 1997-01-08 2000-10-24 Amylin Pharmaceuticals, Inc. Amylin agonist pharmaceutical compositions containing insulin
EP1015493A1 (en) 1997-01-10 2000-07-05 EPIcyte Pharmaceutical, Inc. Novel epithelial tissue targeting agent
TW518235B (en) * 1997-01-15 2003-01-21 Akzo Nobel Nv A gonadotropin-containing pharmaceutical composition with improved stability on prolong storage
US20010007673A1 (en) 1999-11-12 2001-07-12 Merrill Seymour Goldenberg Sustained-release delayed gels
US6113947A (en) * 1997-06-13 2000-09-05 Genentech, Inc. Controlled release microencapsulated NGF formulation
US6287587B2 (en) 1997-07-15 2001-09-11 Takeda Chemical Industries, Ltd. Process for producing sustained-release preparation by in-water drying
DE69811233T2 (de) 1997-10-27 2003-11-20 Merck Patent Gmbh Feste lösungen und dispersionen von eines schlecht wasserlöslichen wirkstoffes
ZA9811127B (en) 1997-12-09 2000-07-11 Lilly Co Eli Stabilized teriparatide solutions.
US6541606B2 (en) 1997-12-31 2003-04-01 Altus Biologics Inc. Stabilized protein crystals formulations containing them and methods of making them
US20020165146A1 (en) * 1998-07-23 2002-11-07 Hoffman James Arthur FSH article of manufacture
PL346127A1 (en) * 1998-07-23 2002-01-28 Lilly Co Eli Fsh and fsh variant formulations, products and methods
FR2782455B3 (fr) * 1998-08-20 2000-09-15 Sanofi Sa Composition pharmaceutique injectable a base d'un sel pharmaceutiquement acceptable du clopidogrel ou de ticlopidine
EP1113799A4 (en) 1998-09-17 2004-06-09 Lilly Co Eli PROTEIN-BASED PREPARATION
WO2001002564A1 (fr) 1999-06-30 2001-01-11 Takeda Chemical Industries, Ltd. Nouveau polypeptide et adn de ce polypeptide
US6573237B2 (en) 2001-03-16 2003-06-03 Eli Lilly And Company Protein formulations
JP2005517012A (ja) 2002-02-08 2005-06-09 アルカーメス コントロールド セラピューティクス，インコーポレイテッド 持続放出のためのポリマーベース組成物

Also Published As

Publication number Publication date
US7741268B2 (en) 2010-06-22
RS20050737A (sr) 2007-11-15
HK1086503A1 (en) 2006-09-22
AU2004226666B2 (en) 2009-09-03
RS57872B1 (sr) 2018-12-31
BRPI0409532B1 (pt) 2019-09-17
AU2004226666B9 (en) 2010-04-08
BRPI0409532A (pt) 2006-04-18
MXPA05010635A (es) 2005-12-12
ATE492292T2 (de) 2011-01-15
EA200501531A1 (ru) 2006-06-30
CA2518903A1 (en) 2004-10-14
KR101105486B1 (ko) 2012-01-13
JP4699991B2 (ja) 2011-06-15
DK1610822T4 (en) 2019-01-14
CA2518903C (en) 2013-02-05
AU2004226666A1 (en) 2004-10-14
NO330214B1 (no) 2011-03-07
PL1610822T5 (pl) 2019-05-31
EP1610822B1 (en) 2010-12-22
AR043972A1 (es) 2005-08-17
KR20050110037A (ko) 2005-11-22
WO2004087213A1 (en) 2004-10-14
NZ542247A (en) 2008-03-28
EP1610822A1 (en) 2006-01-04
HRP20100727T4 (hr) 2018-11-16
SI1610822T1 (sl) 2011-02-28
DK1610822T3 (da) 2011-01-31
EP1610822B2 (en) 2018-09-19
EA012565B1 (ru) 2009-10-30
PL1610822T3 (pl) 2011-06-30
HRP20100727T1 (hr) 2011-02-28
IL171151A (en) 2014-11-30
BRPI0409532B8 (pt) 2021-05-25
SI1610822T2 (sl) 2018-12-31
DE602004030673D1 (de) 2011-02-03
MEP31708A (en) 2010-10-10
WO2004087213A8 (en) 2005-03-17
CY1111291T1 (el) 2015-08-05
PT1610822E (pt) 2011-01-05
ME00217B (me) 2011-02-10
JP2006522072A (ja) 2006-09-28
US20060147480A1 (en) 2006-07-06

Similar Documents

Publication Publication Date Title
NO20054982L (no) Flytende farmasoytiske formuleringer for FSH og LH sammen med et ikke-ionisk surfaktant
DK1575618T3 (da) Dispergerbare farmaceutiske kombinationer
NO20032112L (no) Grensesnitt for visuale og scenegraf
NO20052335D0 (no) Dispergerbare defracirox-tabletter
EP1803551A4 (en) SANDWICH STRUCTURE AND THESE INTEGRATED FORM BODY
DK1530972T3 (da) Fremgangsmåde til screening for parasitpræparaters effektivitet i forebyggelse og kontrol af sygdomme
DZ3433A1 (fr) Echantillonage avec contamination reduite
DE60211785D1 (de) Bilderzeugungsverfahren
EP1666783A4 (en) PIPE CONNECTION AND PIPE CONNECTOR
NO20021510L (no) Avbildningsenhet og dens fremstilling
DE60137595D1 (de) Bilderzeugungsverfahren
DE60229433D1 (de) Isches koppler
DE602005005589D1 (de) Schnellkupplungsvorrichtung sowie Traktor
NO20021511D0 (no) Avbildningsenhet og dens fremstilling
DE60142625D1 (de) Verstärkungsrahmen
EP1397958A4 (en) Haulm killers
MA27371A1 (fr) Formulations à dépôt de courte durée
AU2003282822A8 (en) Tubular member coupling device
AU2003290345A1 (en) Pharmaceutical dissolution testing using a non-ionic surfactant
EP1712762A4 (en) TRANSMISSION SYSTEM CONNECTION
DK1638595T3 (da) Frysetørrede FSH-/LH-formuleringer
DE60204089D1 (de) Bilderzeugungsverfahren
FI20030446L (fi) Artikkelin irrotuslaite ja menetelmä sellaisen käyttämiseksi
EP1757277A4 (en) ORAL PREPARATIONS AND METHOD FOR THEIR MANUFACTURE
FR2839845B1 (fr) Crossbar configurable et procedes associes